Centene Corporation Cash Flow Statement
CNC / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Centene Corporation generated $5.1B in operating cash flow and $4.3B in free cash flow in FY2025. Free cash flow margin was 2.2% of revenue.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.7B | $3.3B | $2.7B | $1.2B | $1.3B | $1.8B | $1.3B | $900.0M | $828.0M | $562.0M | $355.0M | $271.0M | $165.0M | $2.0M | $111.2M |
| Depreciation & Amortization | $1.3B | $1.2B | $1.3B | $1.4B | $1.3B | $1.3B | $643.0M | $495.0M | $361.0M | $278.0M | $111.0M | $89.0M | $67.0M | $66.0M | $58.3M |
| Operating Cash Flow | $5.1B | $154.0M | $8.1B | $6.3B | $4.2B | $5.5B | $1.5B | $1.2B | $1.5B | $1.9B | $658.0M | $1.2B | $382.0M | $279.0M | $261.7M |
| Capital Expenditures | $767.0M | $644.0M | $799.0M | $1.0B | $910.0M | $869.0M | $730.0M | $675.0M | $422.0M | $306.0M | $150.0M | $103.0M | $68.0M | $82.0M | $73.7M |
| Free Cash Flow | $4.3B | -$490.0M | $7.3B | $5.3B | $3.3B | $4.6B | $753.0M | $559.0M | $1.1B | $1.5B | $508.0M | $1.1B | $314.0M | $197.0M | $188.0M |
| Share Buybacks | $475.0M | $3.1B | $1.6B | $3.1B | $297.0M | $626.0M | $75.0M | $71.0M | $65.0M | $63.0M | $53.0M | $29.0M | $19.0M | $13.0M | $7.8M |
| FCF Margin | 2.2% | -0.3% | 4.7% | 3.6% | 2.6% | 4.2% | 1.0% | 0.9% | 2.2% | 3.8% | 2.2% | 6.8% | 2.9% | 2.4% | 3.6% |